mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.092 |
0.009 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.091 |
0.009 |
mRNA |
brivanib |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.01 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
0.01 |
mRNA |
BRD-K96431673 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.01 |
mRNA |
I-BET-762 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.01 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.089 |
0.01 |
mRNA |
Cytarabine |
GDSC1000 |
pan-cancer |
AAC |
0.091 |
0.01 |
mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
-0.18 |
0.01 |